Cannabis for irritable bowel syndrome: IBS, CBD & intestinal pain

Irritable bowel syndrome and the endocannabinoid system

Irritable bowel syndrome (IBS) is the most common functional gastrointestinal disorder – affecting 10-15% of the population. IBS without cause in terms of organic pathology is characterized by abdominal pain, altered stool frequency (diarrhoea, constipation or mixed) and flatulence. The endocannabinoid system is densely distributed throughout the gastrointestinal tract and regulates precisely those functions that are disrupted in IBS.

ECS in the intestine: Gut Brain Axis

The enteric nerve (the “abdominal brain”) contains more neurons than the spinal cord and is closely connected to the ECS. CB1 receptors are located in:
– Enteric neurons (motility control)
– Intestinal epithelial cells (barrier function, secretion)
– Immune cells (mast cells, macrophages in the intestinal wall)
– Afferent sensory nerve fibers (pain and distension)

Endocannabinoids (anandamide, 2-AG) regulate gastrointestinal motility (CB1 inhibits excessive peristalsis), intestinal permeability and pain signals from the intestine.

Clinical endocannabinoid deficit theory in IBS

Ethan Russo’s CEDS theory (2004, 2016) describes IBS as part of a clinical endocannabinoid deficit – alongside migraine and fibromyalgia. Evidence:
– IBS patients have increased FAAH activity → lower anandamide levels
– CB1 polymorphisms associated with IBS severity and abdominal pain
– Anandamide infusion in IBS patients reduces visceral hypersensitivity (animal model)

Study situation: Cannabis and IBS

IBS types and cannabis

IBS-D (diarrhea-dominated): CB1 activation slows intestinal transit → less uncontrolled diarrhea. THC in IBS-D has an antidiarrheal effect (similar to loperamide, but via a different mechanism).

IBS-C (constipation-dominant): Too much CB1 activation can exacerbate constipation. Lower doses of THC + CBD may be better balanced for IBS-C.

IBS-M (mixed): CBD-first: less direct CB1 influence on motility, but anxiolysis (anxiety as an IBS trigger) and inhibition of inflammation.

CBD-specific effect on IBS

CBD works on IBS in several ways:
– Visceral hypersensitivity: TRPV1 desensitization in intestinal nerve fibers → less pain with normal stretching
– Anxiety: Gut-brain axis – anxiety and stress consistently exacerbate IBS. CBD anxiolysis via 5-HT1A can improve IBS symptoms via the psychosomatic route
– Intestinal permeability: CBD strengthens tight junctions in the intestinal epithelium → reduces leaky gut effects

FAQ: Cannabis for irritable bowel syndrome

Summary

IBS and ECS are closely linked: CB1 regulates intestinal motility, visceral pain and permeability. Clinical RCTs show dronabinol and THC significantly reduce visceral hypersensitivity and intestinal transit time. CBD acts via anxiolysis, TRPV1 and tight junction protection. IBS-D benefits from THC (antidiarrheal), IBS-C requires more cautious dosing. Cannabis for fibromyalgia and cannabis for anxiety cover the most common IBS comorbidities.